AzTrials
AzTrials

StressNCT07127575

Scalable Intervention for Stress Management

A study testing Resistance Breathing Device and Electronic Resistance Breathing Device in people with Stress and Diaphragmatic Breathing, run by Livotion, LLC at 1 site in United States.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The purpose of this research is to measure the acceptance of a resistance breathing intervention and to assess whether it produces physiological and subjective effects in a laboratory setting. Read more about this study

Who is it for?
Ages 18 to 30 yearsHealthy volunteers can take part
Conditions the study is for
Stress, Diaphragmatic Breathing
What is being tested?
Resistance Breathing Device and Electronic Resistance Breathing Device
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
1 siteUnited States
Study dates
1 Aug 2025to 30 Sep 2025
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 30 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Be at least 18 years old
  • Be currently enrolled in a college or university
  • Be able to read, speak, and comprehend English
  • Be able and willing to complete a 60-minute study involving heart rate monitoring, survey completion, training, a stress test, and device utilization

Who cannot join

  • -Individuals diagnosed with anxiety or stress and require professional support to cope with these clinical levels of stress or anxiety should not enroll in the study in place of professional assistance.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Milton E Aguirre, PhD contact

7654960782

meaguirr@purdue.edu

Amanda Case, PhD contact

amanda-case@uiowa.edu

United States1 site, 1 recruiting
  • Purdue University

    West Lafayette, Indiana, 47907

    Milton Aguirre, PhD, 7654960782, meaguirr@purdue.edu

    Recruiting

Other trials in United States

About this study

Official title: A Scalable Intervention for Stress Management Practices

The purpose of this research is to measure the acceptance of a resistance breathing intervention and to assess whether it produces physiological and subjective effects in a laboratory setting.

Read the detailed description

College students experience a wide range of stressors during their studies, with many students experiencing levels of stress that can be clinically significant, such as anxiety or depression. Counseling centers on college campuses have seen a rise in students seeking mental health support or stress relief, but there exists a discrepancy in the level of need versus the support that can be provided. Stress management interventions, such as self-care mobile applications and devices, have risen in popularity given their relative accessibility and implementation of stress relieving interventions such as regulated breathing. Regulated breathing has been shown to be a reliable and effective form of stress relief, however its implementation within various eHealth interventions and related devices can come into conflict when used in educational settings. Mobile apps and biofeedback devices (e.g., chest straps, inhalers), can be contextually inappropriate, cumbersome, and potentially stigmatizing for students. To overcome these barriers, the PI developed the AIRpen, a simple, affordable, multi-functional stress management device that is designed to fit into the fabric of students' lives to potentially optimize the delivery, practice, and fidelity of diaphragmatic breathing (DB) interventions in real- world settings. With anecdotal and empirical evidence supporting the device as feasible and acceptable in real-world academic settings, this study will build upon prior work and measure the acceptance of the intervention and assess whether using the original and a "smart" version of the device as a stress relieving tool produces physiological and subjective effects in a laboratory setting.

Being tested
Resistance Breathing Device, Electronic Resistance Breathing Device
Keywords
resistance breathing, stress management

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Resistance Breathing DeviceDevice

    The AIRpen is a multifunctional stress management tool that helps users engage in diaphragmatic breathing at differing resistance levels, as well as other common stress relieving behaviors such as fidgeting

  • Electronic Resistance Breathing DeviceDevice

    The Smart AIRpen functions just as the original AIRpen device and has been augmented with sensors to measure use patterns to determine whether the AIRpen is being used for fidgeting or breathing.

Study groups in NCT07127575
Study groupRoleWhat they receive
Base AIRpenExperimentalIn this arm, participants will utilize an AIRpen after completing an arithmetic based stress test during a decompression period. Participants will engage in diaphragmatic breathing and other stress reducing behaviors like fidgeting or clicking using the AIRpen while physiological data is measured with an ear sensor and audio recordings.
Receives: Device: Resistance Breathing Device
Smart AIRpenExperimentalIn this arm, participants will utilize a SMART AIRpen after completing an arithmetic based stress test during a decompression period. Participants will engage in diaphragmatic breathing and other stress reducing behaviors like fidgeting or clicking using the Smart AIRpen while physiological data is measured with an ear sensor and audio recordings.
Receives: Device: Electronic Resistance Breathing Device
No AIRpenNo interventionIn this arm, participants will be asked to sit quietly following an arithmetic based stress test during a decompression period. Physiological data will be measured with an ear sensor and audio recordings.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Device Acceptability as Measured by the Acceptability of Intervention Measure (AIM)

    The AIM measure is designed to assess the acceptability of a intervention, and has been adapted in relation to the AIRpen. Participants rate statements related to their usage and experience of the AIRpen and AIRpen website, with ratings ranging from "Completely Disagree" (1), to "Completely Agree" (5). Higher scores indicate higher acceptability of the intervention.

    Measured: From enrollment to end of 1 hour study period.

  2. Device Usability as Measured by a Modified Version of the System Usability Scale (SUS)

    The System Usability Scale is a 10-item measure that address the usability and learnability of a system. The SUS has been modified to reflect the AIRpen intervention. Statements are ranked on a Likert scale for 1-5, with 1 indicating "Strongly Disagree" and 5 indicating "Strongly Agree". Raw scores are converted into a final score that ranges from 0-100, with a larger score indicating greater usability.

    Measured: From enrollment until completion of 1 hour study period.

Secondary outcomes (2)
  1. Perceived Stress as Measured by the Perceived Stress Scale (PSS_10)

    The Perceived Stress Scale is a measure used to assess perceptions of recent stress. Individual scores on the PSS can range from 0 to 40 with higher scores indicating higher perceived stress.

    Measured: From enrollment to the end of the 1 hour study period

  2. Physiological Stress as Assessed with Heart Rate Monitoring

    Measured: From study enrollment to end of 1 hour study period

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 Aug 2025
  2. Study start1 Aug 2025
  3. Primary completion30 Sep 2025 (estimated)
  4. Study completion30 Sep 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
Participants will be assigned to one of three conditions. 20 will be in the no pen condition, 20 will be in the original AIRpen condition, and 20 will be in the smart AIRpen condition.
Masking
None (open label)
Enrolment
60 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07127575
Sponsor's protocol ID
IRB-2025-935
Other IDs
1R41AT012854-01
Status last verified
Aug 2025
First submitted
1 Aug 2025
Last updated
17 Aug 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Resistance Breathing Device and Electronic Resistance Breathing Device in people with Stress and Diaphragmatic Breathing, run by Livotion, LLC at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 17 Aug 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Milton E Aguirre, PhD (7654960782, meaguirr@purdue.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Device Acceptability as Measured by the Acceptability of Intervention Measure (AIM) (time frame: From enrollment to end of 1 hour study period.). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Aug 2025.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in